Guillain–Barre Syndrome in Patients With Cystic Fibrosis: A Case Series

J D Nolan, My T. Thai, Vanessa Moore, Daniel Henderson, David W. ReidRespirology 2025 · DOI

TL;DR

This case series highlights the rare but significant occurrence of Guillain-Barré Syndrome (GBS) in adults with Cystic Fibrosis (CF). It underscores the complex interplay between chronic CF-related inflammation, infections, and the potential for autoimmune neurological complications, emphasizing the need for increased awareness and prompt management in this vulnerable patient population.

What Problem Does This Paper Address?

Cystic Fibrosis (CF) is a genetic disorder primarily affecting the lungs, leading to chronic respiratory infections and progressive lung damage. While neurological complications are not unheard of in CF, they are typically attributed to factors like diabetes, micronutrient deficiencies, or unknown immunological causes. Guillain-Barré Syndrome (GBS), a serious autoimmune disorder affecting the peripheral nervous system, is usually triggered by infections. However, the occurrence of GBS in individuals with CF, particularly adults, is exceptionally rare and poorly understood. This paper addresses the gap in knowledge regarding the association between CF and GBS, exploring potential triggers and the unique challenges in managing such cases within the context of pre-existing severe lung disease and systemic inflammation.

Methods

This paper presents a retrospective case series of four adult patients with Cystic Fibrosis who developed Guillain-Barré Syndrome. The authors reviewed patient medical histories, clinical presentations, diagnostic findings (including nerve conduction studies, lumbar puncture, and antibody testing), treatments administered, and clinical outcomes. The methodology involved detailed case-by-case analysis to identify commonalities, potential precipitating factors, and the impact of GBS on CF management.

Datasets

Not discussed in the paper.

Key Insights and Ideas

  • Rare but Significant Association: The paper establishes that GBS, while rare, can occur in adults with CF, presenting a unique clinical challenge.
  • Complex Triggers: While respiratory or gastrointestinal infections are common GBS triggers, the cases suggest that in CF patients, chronic inflammation, potential autoimmune phenomena, or even the dysfunctional CFTR protein itself might play a contributory role.
  • Detrimental Impact on CF Care: GBS significantly complicates the management of CF, impacting crucial aspects like airway clearance, nutrition, and hydration, which are already challenging in these patients.
  • Variable Outcomes: The case series demonstrates a range of outcomes, from slow neurological recovery to permanent deficits and, tragically, one fatality, highlighting the severity of GBS in this population.
  • Need for Increased Awareness: The authors emphasize the importance of a high index of suspicion for GBS among CF physicians to ensure earlier diagnosis and management, potentially improving patient outcomes.

Key Results

The case series describes four adult CF patients who developed GBS.

  • Patient Demographics: Ages ranged from 18 to 54 years.
  • Clinical Presentation: All patients experienced progressive peripheral weakness, with varying degrees of sensory changes, cranial nerve palsies, and respiratory involvement.
  • Diagnostic Findings: Nerve conduction studies revealed axonal loss and/or demyelination. Lumbar punctures showed albuminocytologic dissociation in two cases. Antibody testing was negative for anti-GM1 gangliosides in all cases.
  • Treatment: Patients received standard GBS treatments, including intravenous immunoglobulin (IVIg) and plasma exchange (PLEX).
  • Outcomes:
    • Case 1: Persistent mild facial nerve palsy at 2 months, full neurological recovery at 6 months.
  • Case 2: Residual peripheral lower limb paraplegia and cranial nerve palsy after extensive ICU and rehabilitation stays.
  • Case 3: Deteriorated respiratory status due to CF exacerbation and died on day 36 of hospitalization.
  • Case 4: Residual dysarthria at long-term follow-up.
  • Precipitating Factors: Identified triggers included viral respiratory tract infections in two cases, while no clear trigger was identified in the other two. Medications (tacrolimus, cyclosporin) were identified as a potential cause in one case and were switched.

Limitations and Future Work

  • Small Sample Size: The primary limitation is the small number of cases (four), which prevents definitive conclusions about the incidence, specific risk factors, or optimal management strategies for GBS in CF.
  • Retrospective Nature: As a case series, it relies on retrospective data, which can be subject to recall bias and incomplete information.
  • Unidentified Triggers: In two of the four cases, a clear inciting incident for GBS could not be identified, suggesting that other, less obvious triggers may be at play in CF patients.
  • Future Work: The authors suggest that future research should focus on larger, multi-center studies to better understand the incidence, pathogenesis, and optimal management of GBS in CF. Further investigation into the role of chronic inflammation, CFTR dysfunction, and potential autoimmune mechanisms is warranted. The paper also calls for increased awareness and prompt neurological referral for CF patients presenting with suggestive symptoms.

Summary updated

Abstract

People with cystic fibrosis (CF) typically experience chronic respiratory infections, but neurological sequelae are rare. Guillain-Barre Syndrome (GBS) is classically precipitated by a respiratory or gastrointestinal infection, although other rarer aetiologies exist. This case series outlines four adults with CF who developed GBS. The association with acute and chronic respiratory infections in people with CF is explored, as well as other potential precipitants. An autoimmune phenomenon in the context of chronic systemic inflammation or a possible contributory role of dysfunctional CFTR protein is also considered.
BibTeX
@inproceedings{nolan2025guillainbarre,
  author = {J D Nolan and My T. Thai and Vanessa Moore and Daniel Henderson and David W. Reid},
  title = {{Guillain–Barre Syndrome in Patients With Cystic Fibrosis: A Case Series}},
  booktitle = {Respirology},
  year = {2025},
  doi = {10.1002/rcr2.70308},
}
Figure